Clinical trial · Interventional
Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
"For lesions in the skull base, including meningiomas, chordomas and pituitary tumors, endoscopic surgery has replaced traditional microscopes as the mainstream procedure. Although neurosurgeons can enlarge the surgical area using a neuroendoscope, it does not provide any information on the morphology and location of anatomical structures beneath visible surfaces. Due to the complex anatomical relationships of adjacent structures in the skull base, lesions occurring here are often located deep within anatomy that is difficult to fully expose and remove with endoscopic surgery alone. Especially when dealing with larger tumors that surround major arteries and nerves, limited visibility at surface level can easily damage blood vessels or nerves causing complications such as bleeding during or after surgery, deformities or functional impairments. The purpose of this study is to explore how augmented reality (AR) technology can highlight important anatomical structures in a neuroendoscope's field of view to optimize surgical visibility beyond what is possible with just an endoscope alone. This will make it easier for surgeons to distinguish deeper anatomical structures and reduce intraoperative and postoperative complications associated with endoscopic surgery."
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pituitary Neoplasms | Pituitary Gland Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Performing endoscopic transnasal skull base surgery with AR-integrated endoscope | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- surgery with AR-integrated endoscope
- description
- Performing endoscopic transnasal skull base surgery with AR-integrated endoscope
- interventionNames
- Device: Performing endoscopic transnasal skull base surgery with AR-integrated endoscope
Primary outcomes (2)
- measure
- Postoperative Recovery of Transnasal Surgery
- timeFrame
- at the time points of baseline,3 months, 6 months and 1 year after surgery
- description
- Observe whether the preoperative symptoms (including endocrine abnormalities, impaired visual field, headache, etc.) were alleviated after surgery.
- measure
- Postoperative complication
- timeFrame
- at the time points of baseline,3 months, 6 months and 1 year after surgery
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients who are suitable for Transnasal endoscopic surgery 。 * Patients who have performed thin-layer head MRI and CTA scans before surgery. Exclusion Criteria: * Patients without clear preoperative imaging data. * Patients who do not agree to receive the assistance of AR fusion neuroendoscopy. * Patients with incomplete medical records.
References
Publications (0)
Data not yet available